BCL2L11 and melanoma: These findings argue that efficient melanoma cell killing in our system requires dysregulation of multiple survival signaling modules, such as ERK-BAD/BIM and AMPK-mTOR-autophagy and ERK-STAT3-MCL-1, shifting their activities/functions from maintaining cell viability to permitting tumor cell death.